Hallmark Jingle Stop Tour Visits CHOP to Spread Joy
Oct 18, 2024
Actors and actresses from this year’s original Hallmark holiday movies interacted with patients and their families through various holiday-themed stations.
<p>Brachial plexus and peripheral nerve injuries affect the nerves that supply the arms and hands, and include birth-related palsies, trauma and peripheral tumors.</p>
Oct 18, 2024
Actors and actresses from this year’s original Hallmark holiday movies interacted with patients and their families through various holiday-themed stations.
Learn why whooping cough (pertussis) is making a comeback, what symptoms are, and how to protect your family.
Read this case study to learn how spinal surgery can help improve mobility for children with spastic diplegic cerebral palsy.
This case study discusses when primary care professionals should refer their patients to a specialist.
Oct 16, 2024
Researchers at Children’s Hospital of Philadelphia (CHOP) announced the results of a new study highlighting significant genetic links in speech and language disorders in children.
Oct 16, 2024
Researchers from Children’s Hospital of Philadelphia (CHOP) and Vanderbilt University Medical Center were awarded a $7.37 million RC2 grant from the National Institutes of Health (NIH) to lead a five-year multisite project across the U.S. focused on kidney stone disease research.
This year, many children will spend the holidays in the hospital. Brighten the season for them and their families by creating a virtual toy drive—a fun and easy way to raise funds to buy gifts for kids in CHOP this holiday season.
Researchers at Children’s Hospital of Philadelphia (CHOP) have elucidated the significant role that alternative splicing – a process whereby a single gene produces multiple proteins by rearranging its messenger RNA segments in different combinations – plays in resistance to chemotherapy in relapsed or refractory B-cell acute lymphoblastic leukemia (B-ALL). The study published today in the journal Cancer Research.
The vaccine is the first mRNA vaccine against C. difficile and would be the first vaccine in general to successfully ward off the bacterial infection.
Oct 10, 2024
Researchers aim to develop personalized therapies for urea cycle disorders and other genetic conditions using advanced CRISPR technology.